Aktivne farmacevtske sestavine
Progestagen in estrogen | |||
ime izdelka | Specifikacija | Odobreno | št. CAS |
progesteron | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Medroksiprogesteronacetat | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrol acetat | CP/EP/USP | DMF pod vložitvijo | 595-33-5 |
Mifepriston | CP/IP | DMF/GMP | 84371-65-3 |
Ciproteron acetat | CP/EP | CEP/TGA/GMP | 427-51-0 |
levonorgestrel | CP/EP/USP | DMF/GMP/CEPin postopek | 797-63-7 |
Drospirenon | EP/USP | DMF pod vložitvijo | 67392-87-4 |
Gestoden | CP/EP | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP | DMF | 50-28-2 |
Estriol | CP/EP/USP | V okviru raziskav in razvoja | 50-27-1 |
Etinilestradiol | CP/EP/USP | DMF/GMP | 57-63-6 |
Estradiol Valerat | CP | DMF pod vložitvijo | 979-32-8 |
Tibolon | CP/EP | DMF | 5630-53-5 |
Dienogest | EP | DMF pod vložitvijo | 65928-58-7 |
Fulvestrant | EP/USP | V okviru raziskav in razvoja | 129453-61-8 |
Androgen | |||
ime izdelka | Specifikacija | Odobreno | št. CAS |
Finasterid | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasterid | EP/USP | CEP/DMF | 164656-23-9 |
Abirateronacetat | CP/USP | DMF | 154229-18-2 |
Testosteron | CP/EP/USP | DMF/CEP v postopku | 58-22-0 |
Testosteron undekanoat | CP | DMF pod vložitvijo | 5949-44-0 |
Testosteron Cypionate | USP | DMF pod vložitvijo | 58-20-8 |
DHEA (prasteron) | FP/notranji | DMF/WC/Košer | 53-43-0 |
Kortikalni hormon | |||
ime izdelka | Specifikacija | Odobreno | št. CAS |
Budezonid | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonid | USP | DMF | 638-94-8 |
Eplerenon | EP | CEP/FDA | 107724-20-9 |
Metilprednizolon | CP/EP/USP | DMF/WC | 83-43-2 |
Metilprednizolon hemisukcinat | CP/EP/USP | DMF/WC | 2921-57-5 |
Flutikazon propionat | CP/EP/USP | DMF | 80474- 14-2 |
Flutikazon furoat | V hiši | V okviru raziskav in razvoja | 397864-44-7 |
Mometazon furoat | CP/EP/USP | V okviru raziskav in razvoja | 83919-23-7 |
drugi | |||
ime izdelka | Specifikacija | Odobreno | št. CAS |
okskarbazepin | CP/EP/USP | CEP/DMF/GMP | 28721-07-5 |
Eslikarbazepinacetat | V hiši | DMF pod vložitvijo | 236395-14-5 |
ganciklovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciklovir hidroklorid | USP | DMF pod vložitvijo | 175865-59-5 |
Oseltamivir fosfat | CP/EP/USP | DMF | 204255- 11-8 |
Nintedanib Esylate | V hiši | DMF | 656247-18-6 |
Revefenacin | V hiši | DMF v postopku | 864750-70-9 |
Mirabegron | V hiši | DMF v postopku | 223673-61-8 |
kariprazin hidroklorid | V hiši | DMF v postopku | 1083076-69-0 |
Lasmiditan sukcinat | V hiši | DMF v postopku | 439239-92-6 |
lulikonazol | V hiši | DMF v postopku | 187164-19-8 |
ime izdelka | Specifikacija | Odobreno | št. CAS |
16α-hidroksiprednizolon | Najmanj 99,0 % | DMF | 13951-70-7 |
16α-hidroksiprednizolon acetat | Najmanj 98,0 % | DMF | 86401-80-1 |
21-acetoksi-11β-hidroksipregna-1,4,16-trien-3,20-dion | Najmanj 98,0 % | TP | 3044-42-6 |
DHEA (prasteron) | Najmanj 99,0 % | DMF/WC | 53-43-0 |
DHEA acetat (prasteron acetat) | Najmanj 99,0 % | DMF | 853-23-6 |
Epiandrosteron | Najmanj 99,0 % | TP | 481-29-8 |
Abirateron | V hiši | DMF | 154229-19-3 |
Triacetil-ganciklovir | Najmanj 98,5 % | TP | 86357-14-4 |
Mono-acetil ganciklovir | Najmanj 97 % | TP | 194254-40-0 |
16-dehidropregnenolon acetat ï¼16-DPAï¼ | Najmanj 99,0 % | TP | 979-02-2 |
Pregnenolon acetat | Najmanj 98,0 % | TP/ Košer | 1778-02-5 |
Pregnenolon | Najmanj 99,0 % | TP/košer | 145-13-1 |
3-okso-4-androsten-17β-karboksilna kislina | Najmanj 99,0 % | TP | 302-97-6 |
4-aza-5α-androstan-3-okso-17β-karboksilna kislina | Najmanj 98,0 % | DMF | 103335-55-3 |
4-aza-5α-androstan-1-en-3-okso-17β-karboksilna kislina | Najmanj 98,0 % | DMF | 104239-97-6 |
N-tert-butil-3-okso-4-aza-5α-androst-17β-karboksamid | Najmanj 98,0 % | DMF | 98319-24-5 |
6-kloro-1α-klorometil-3,20-diokso-pregna-4,6-dien-17α-acetoksi | Najmanj 98,0 % | DMF | 17183-98-1 |
Estron | USP36 | TP | 53-16-7 |
Flumetazon | Najmanj 98,0 % | TP | 2135-17-3 |